Meihao Medical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	330	222	222	261	297	-
Market Cap Growth	77.42%	-	-14.92%	-12.12%	-	-
Enterprise Value	246	177	118	138	291	-
Last Close Price	0.55	0.37	0.37	0.42	0.48	-
PE Ratio	-	-	-	-	9.23	-
PS Ratio	2.92	1.96	2.79	3.22	2.06	-
PB Ratio	2.77	1.86	1.73	1.43	1.48	-
P/TBV Ratio	3.15	2.12	1.94	1.44	1.49	-
P/FCF Ratio	48.88	32.89	-	4645.34	10.87	-
P/OCF Ratio	19.27	12.96	-	42.06	8.26	-
EV/Sales Ratio	2.17	1.57	1.49	1.70	2.02	-
EV/EBITDA Ratio	-	-	-	-	5.29	-
EV/EBIT Ratio	-	-	-	-	6.05	-
EV/FCF Ratio	36.45	26.27	-	2451.28	10.66	-
Debt / Equity Ratio	0.13	0.13	0.28	0.20	0.21	0.88
Debt / EBITDA Ratio	-	-	-	10.95	0.66	0.80
Debt / FCF Ratio	2.23	2.23	-	661.20	1.52	1.56
Net Debt / Equity Ratio	-0.72	-0.72	-0.37	-0.65	-0.30	0.06
Net Debt / EBITDA Ratio	6.30	6.30	1.71	29.59	-1.09	0.07
Net Debt / FCF Ratio	-12.64	-12.64	2.28	-2122.55	-2.19	0.11
Asset Turnover	0.55	0.55	0.35	0.30	0.66	0.91
Inventory Turnover	23.24	23.24	19.47	16.33	20.23	19.45
Quick Ratio	2.06	2.06	2.28	3.87	4.17	0.96
Current Ratio	2.15	2.15	2.45	4.01	4.28	1.16
Return on Equity (ROE)	-12.44%	-12.44%	-22.82%	-7.93%	25.03%	93.39%
Return on Assets (ROA)	-6.96%	-6.96%	-9.71%	-2.82%	13.76%	24.03%
Return on Invested Capital (ROIC)	-68.01%	-39.08%	-49.48%	-12.02%	33.86%	97.22%
Return on Capital Employed (ROCE)	-15.40%	-15.40%	-21.90%	-5.60%	20.10%	51.80%
Earnings Yield	-4.83%	-7.19%	-15.54%	-5.74%	10.83%	-
FCF Yield	2.05%	3.04%	-9.46%	0.02%	9.20%	-
Dividend Yield	-	-	-	2.36%	-	-
Buyback Yield / Dilution	0.03%	0.03%	3.01%	-31.18%	-1.64%	-
Total Shareholder Return	0.03%	0.03%	3.01%	-28.82%	-1.64%	-